FDA Suspends Experimental Johnson and Johnson COVID Shot Linked to Fatal Blood Clots

The CDC & FDA are reviewing data involving six reported US cases of a rare and severe type of blood clot in individuals after receiving the vaccine. Dr. Marks said the US believes the problem in the Johnson and Johnson and AstraZeneca vaccines is “related” to the adenovirus platform.